T1458 |
Epalrestat
|
82159-09-9
|
99.2%
|
|
Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic ne...
|
T15568 |
Imirestat
|
89391-50-4
|
99.08%
|
|
Imirestat (HOE 843) is an aldose reductase inhibitor that can be used in diabetes research.
|
T17114 |
Tolrestat
|
82964-04-3
|
99.02%
|
|
Tolrestat (AY-27773) is a potent inhibitor of aldose reductase (IC50 = 35 nM).
|
T16756 |
Risarestat
|
79714-31-1
|
98.39%
|
|
Risarestat (CT-112) is a potent aldose reductase inhibitor and thyroid hormone receptor (TR) antagonist for the treatment of hypoglycemia.
|
T23403 |
Sulindac sulfone
|
59864-04-9
|
98.19%
|
|
Sulindac sulfone is a metabolite of the nonsteroidal anti-inflammatory drug sulindac.
|
T2013 |
Ponalrestat
|
72702-95-5
|
98.05%
|
|
Ponalrestat is an aldose reductase inhibitor.
|
T7478 |
2-Chloro-1-(4-fluorobenzyl)benzimidazole
|
84946-20-3
|
98%
|
|
2-Chloro-1-(4-fluorobenzyl)benzimidazole is an inhibitor of aldose reductase (ALR2).
|
T3665 |
Tectoridin
|
611-40-5
|
98%
|
|
Tectoridin (Shekanin) possesses an estrogenic and thyroid hormone-like agent by activating estrogen and thyroid hormone receptors. Tectoridin has anti-oxidant, a...
|
T5S0543 |
Isocurcumenol
|
24063-71-6
|
98%
|
|
1. Isocurcumenol inhibits 5α-reductase which converts testosterone to dihydrotestosterone (DHT).
|
T71703 |
Turosteride
|
137099-09-3
|
97.39%
|
|
Turosteride is a small molecule steroidal 5α-reductase (5α-reductase) inhibitor.Turosteride has antitumor activity for the treatment of oncologic diseases and ge...
|
T6102 |
2'-acetylacteoside
|
94492-24-7
|
97.38%
|
|
2'-Acetylacteoside has antioxidative activity. It can significantly attenuate glutamate-induced neurotoxicity at concentrations ranging from 0.1 to 10 μM. 2'-Ace...
|
T22757 |
EBPC
|
4450-98-0
|
95.00%
|
|
EBPC is an inhibitor of aldose reductase.
|
T33389 |
Minalrestat
|
129688-50-2
|
100%
|
|
Minalrestat(ARI-509) is an orally active and potent aldose reductase inhibitor for the study of impaired microvascular reactivity in diabetic patients.
|
T5015 |
Gonadorelin Acetate (33515-09-2 free base)
|
71447-49-9
|
100%
|
|
Gonadorelin Acetate (33515-09-2 free base) (Luteinizing Hormone Releasing Hormone (LH-RH)) is hypothalamic neuropeptide which plays a key role in the control of ...
|
T3915 |
Ginsenoside Ro
|
34367-04-9
|
|
|
Ginsenoside Ro (Chikusetsusaponin V) can reduce TXA2 production, weakly reduce COX-1 and TXAS activities, and has antiplatelet effects as a Ca2+ antagonist with ...
|
T77523 |
ALR2-IN-1
|
2799695-54-6
|
|
|
ALR2-IN-1 is a potent and selective ALR2 inhibitor with an IC50 value of 1.42 μM.ALR2-IN-1 possesses both antiglycemic and antioxidant activities and can be used...
|
TN1661 |
Ganoderic acid C2
|
103773-62-2
|
98%
|
|
Ganoderic acid C2 has anti-inflammatory,and anti-tumor-promoting activities. Ganoderic acid C2 can inhibit histamine release, it also has inhibitory effects on t...
|
T35317 |
Zopolrestat
|
110703-94-1
|
98%
|
|
Zopolrestat (CP 73850) is a potent inhibitor of aldose reductase (IC50 = 3.1 nM).
|
T0488 |
Finasteride
|
98319-26-7
|
98%
|
|
Finasteride (MK-906) is an oral inhibitor of active testosterone 5-alpha-reductase and Ki value is 10 nM.
|
T4918 |
DL-Glyceraldehyde
|
56-82-6
|
98%
|
|
DL-Glyceraldehyde (Glyceric aldehyde) is produced from the action of the enzyme glyceraldehyde dehydrogenase, which converts glycerol to glyceraldehyde using NAD...
|